샘플 요청 목록

 카트 문의
시장보고서
상품코드
1727996

안검 수술 시장 규모, 점유율, 동향 분석 보고서 : 수술 유형별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Eyelid Surgery Market Size, Share & Trends Analysis Report By Procedure Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

안검 수술 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 안검 수술 세계 시장 규모는 2030년까지 101억 5,000만 달러에 이를 것으로 예측되며, 예측 기간 동안 CAGR 5.6%로 성장할 것으로 예측됩니다.

노년 인구 증가에 영향을 받은 눈과 관련된 문제 증가는 시장 성장에 기여하는 주요 요인 중 하나입니다. 국제미용성형외과학회(ISAPS)에 따르면, 2023년 전 세계적으로 170만 건 이상의 눈꺼풀 수술이 시행되었으며, 이는 전년 대비 24% 증가한 수치입니다.

낮은 침습 수술에 대한 선호도 증가는 시장 확대를 뒷받침하는 중요한 요인입니다. 회복 기간 단축, 환자 편의성 향상 및 소요 시간 단축 등 이러한 기술과 관련된 이점은 예측 기간을 통해 고급 눈꺼풀 수술 기술 수요를 촉진할 것으로 예측됩니다. Rinsada's eyelid retractor와 같은 혁신적인 방법의 개발로 대표되는 이 분야의 기술적 진보는 관련 위험을 완화하고 결과를 개선함으로써 수술의 매력을 더욱 향상시키고 있습니다.

시장의 유명 기업에 의한 최근 활동도 업계의 성장에 기여하고 있습니다. 이 투자는 눈꺼풀 성형술과 관련된 과제를 해결하기 위해 특별히 설계된 의료기기인 Ziplyft의 개발과 상업화를 가속화하는 것을 목적으로 하며, 업계 내에서 지속적인 혁신과 투자가 이루어지고 있음을 보여줍니다.

안검 수술 시장 보고서 하이라이트

  • 북미는 전 시장 점유율의 37.0% 이상을 차지하고, 전 지역 중에서 가장 우세합니다. 이것은 노인 인구 증가나 저침습 기술 등의 요인에 의한 것입니다.
  • 상안검 수술은 눈가의 치료와 미용에 현저하게 응용되고 있기 때문에 2024년에는 55.0% 이상의 점유율을 차지했으며, 수기 분야에서는 우위를 차지하고 있습니다.
  • 클리닉과 스파 센터 부문은 의료 관광 증가와 첨단 기술의 지리적 보급으로 2024년에 65.0% 이상의 최대 시장 점유율을 차지했습니다.
  • 고급 의료 도구와 기술 채택이 증가함에 따라 시장 수요가 증가할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 안검의 수술 시장의 변수, 동향, 범위

  • 시장 계통 전망
    • 상위 시장 전망
    • 관련/부수 시장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 안검의 수술 시장 분석 툴
    • 업계 분석 - Porter's Five Forces 분석
    • PESTEL 분석

제4장 안검의 수술 : 수술 유형별 추정 및 동향 분석

  • 수술 유형별 대시보드
  • 안검의 수술 시장 : 수술 유형별 변동 분석
  • 세계의 눈꺼풀 수술 시장 규모와 동향 분석(수술별, 2018-2030년)
  • 상안검의 수술
    • 2018-2030년까지 시장 추정 및 예측
  • 하안검의 수술
    • 2018-2030년까지 시장 추정 및 예측

제5장 안검의 수술 시장 : 최종 용도별 추정·동향 분석

  • 최종 용도별 대시보드
  • 안검의 수술 시장 : 최종 용도별 변동 분석
  • 세계의 눈꺼풀 수술 시장 규모와 동향 분석(최종 용도별, 2018-2030년)
  • 병원
  • 클리닉과 스파 센터

제6장 안검의 수술 시장 : 지역별 추정·동향 분석

  • 지역별 시장 대시보드
  • 지역별 시장 점유율 분석, 2024년 및 2030년
  • 지역별 안검 수술 시장 : 주요 포인트
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 호주
    • 한국
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제7장 경쟁 구도

  • 주요 시장 진출기업에 의한 최근의 동향과 영향 분석
  • 기업/경쟁의 분류
  • 벤더 상황
    • Key company heat map analysis, 2024
  • 기업 프로파일
    • Integra LifeSciences Corporation
    • Stanford Health Care
    • Surgical Holdings
    • Stryker
    • American Society of Plastic Surgeons
    • London Bridge Plastic Surgery
    • Montenegro Clinic of Plastic Surgery
    • Shoyukai Medical Association
SHW 25.06.05

Eyelid Surgery Market Growth & Trends:

The global eyelid surgery market size is anticipated to reach USD 10.15 billion by 2030 and is projected to expand at a CAGR of 5.6% during the forecast period, according to a new report by Grand View Research, Inc. The rising eye-related problems influenced by the growing geriatric population is one of the major factors contributing to the market growth. According to the International Society of Aesthetic Plastic Surgery (ISAPS), over 1.7 million eyelid surgeries were performed globally in 2023, marking a substantial 24% increase compared to the preceding year. This demographic trend underscores the rising need for surgical interventions to address age-related conditions such as ptosis and baggy eyelids.

The escalating preference for minimally invasive procedures is a key factor propelling market expansion. The advantages associated with these techniques, including faster recovery periods, enhanced patient comfort, and shorter turnaround times, are anticipated to fuel demand for advanced eyelid surgery techniques throughout the forecast period. Technological advancements in the field, exemplified by the development of innovative methods like Rinsada's eyelid retractor, have further augmented the procedure's appeal by reducing associated risks and improving outcomes.

Recent activities among prominent companies in the market are also contributing to industry growth. Notably, in July 2024, Osheru, a medical device company specializing in innovative skin surgery solutions, announced the successful completion of a funding round that garnered over USD 4.0 million. This investment intended to accelerate the development and commercialization of Ziplyft, a medical device specifically designed to address challenges associated with blepharoplasty, indicating ongoing innovation and investment within the industry.

Eyelid Surgery Market Report Highlights:

  • North America is the most dominant among all regions, with more than 37.0% of the total market share, driven by factors such as increase in geriatric population and minimally invasive technology
  • Upper eyelid surgery dominated the procedure segment with more than 55.0% share in 2024 owing to its prominent application in curing and beautifying eyes
  • The clinics and spa centers segment held the largest market share of over 65.0% in 2024 due to the increase in medical tourism and the geographical proliferation of advanced technology
  • Increasing adoption of advanced medical tools and techniques is anticipated to boost market demand

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Procedure
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Procedure outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Eyelid Surgery Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Eyelid Surgery Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Eyelid Surgery: Procedure Estimates & Trend Analysis

  • 4.1. Procedure Segment Dashboard
  • 4.2. Eyelid Surgery Market: Procedure Movement Analysis
  • 4.3. Global Eyelid Surgery Market Size & Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
  • 4.4. Upper Eyelid Surgery
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Lower Eyelid Surgery
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Eyelid Surgery Market: End Use Estimates & Trend Analysis

  • 5.2. Application Segment Dashboard
  • 5.3. Eyelid Surgery Market: Application Movement Analysis
  • 5.4. Global Eyelid Surgery Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.5. Hospitals
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Clinic and Spa Centers
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Eyelid Surgery Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Eyelid Surgery Market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Denmark
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Norway
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. China
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Argentina
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Middle East & Africa
    • 6.8.1. South Africa
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework/ reimbursement structure
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Integra LifeSciences Corporation
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Stanford Health Care
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Surgical Holdings
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Stryker
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. American Society of Plastic Surgeons
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. London Bridge Plastic Surgery
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Montenegro Clinic of Plastic Surgery
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Shoyukai Medical Association
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제